Clinical trial · Observational
Evaluation of the Role of Early Second Look TURBT in Management of High Risk Non Muscle Invasive Bladder Cancer
NCT07642102CI-TRIAL-00114438completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The aim is to evaluate the intraoperative, postoperative and pathologic findings of early second look TURBT and the factors affecting these findings to assess the value of early second TURBT in the management of high risk NMIBC.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Bladder (Urothelial, Transitional Cell) Cancer Superficial (Non-Invasive) | — | UNRESOLVED | — |
| Transurethral Resection of Bladder Tumor | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| early second look transurethral resection of bladder tumor | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- patients with non muscle invasive bladder cancer after transurethral resection of bladder tumor
- interventionNames
- Procedure: early second look transurethral resection of bladder tumor
Primary outcomes (1)
- measure
- presence of pathologically positive tumor
- timeFrame
- 6 weeks
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * patients underwent initial complete resection TURBT with high risk non muscle invasive bladder cancer including: High grade T1 Any carcinoma in situ Any recurrent high grade Ta High grade Ta tumor size is more than 3 cm Any BCG failure in high grade patient Any variant histology Lymphovascular invasion High grade prostatic urethral involvement Exclusion Criteria: * \- Low risk non muscle invasive bladder cancer * intermediate risk non muscle invasive bladder cancer * muscle invasive bladder cancer * metastatic bladder cancer (positive lymph nodes or distant metastasis ) * absent muscle layer in the initial TURBT biopsies * incomplete resection initial TURBT
References
Publications (0)
Data not yet available
No reference posted for this study.